Director at Standex (NYSE: SXI) logs small 50-share stock sale

Rhea-AI Filing Summary

Standex International director Thomas E. Chorman sold 50 shares of Common Stock in an open-market transaction. The shares were sold at a price of $272.82 per share.

After this sale, Chorman directly holds 12,466 shares. The transaction was executed under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating it was pre-scheduled.

Insider Trade Summary 10b5-1

Net Seller: 50 shares ($13,641)

Net Sell 1 txn

Insider CHORMAN THOMAS E

Role null

Sold 50 shs ($14K)

Type	Security	Shares	Price	Value
Sale	Common Stock	50	$272.82	$14K

Holdings After Transaction: Common Stock — 12,466 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 50 shares Sale price per share: $272.82 per share Shares held after sale: 12,466 shares +2 more

5 metrics

Shares sold 50 shares Open-market sale on 2026-06-01

Sale price per share $272.82 per share Common Stock transaction

Shares held after sale 12,466 shares Direct ownership following transaction

Total shares sold in filing 50 shares transactionSummary sellShares

Net buy/sell shares -50 shares Net-sell direction in transactionSummary

Key Terms

Common Stock, open-market sale, Rule 10b5-1 trading plan

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Rule 10b5-1 trading plan regulatory

"Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHORMAN THOMAS E

(Last) (First) (Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, SUITE 300

(Street)

SALEM NEW HAMPSHIRE 03079

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S(1)		50	D	$272.82	12,466	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

	/s/ Alan J. Glass	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Standex (SXI) director Thomas E. Chorman report in this Form 4?

Thomas E. Chorman reported an open-market sale of 50 Standex Common Stock shares. The transaction occurred at $272.82 per share and was executed under a pre-existing Rule 10b5-1 trading plan, indicating the sale was scheduled in advance rather than opportunistic.

How many Standex (SXI) shares did the director sell and at what price?

The director sold 50 shares of Standex Common Stock at $272.82 per share. This small trade reflects a limited disposition of shares, with the transaction coded as an open-market or private sale under SEC transaction code “S.”

How many Standex (SXI) shares does Thomas E. Chorman hold after this transaction?

After the reported sale, Thomas E. Chorman directly holds 12,466 Standex Common Stock shares. This remaining position shows that the 50-share sale represents only a small portion of his overall direct holdings in the company.

Was the Standex (SXI) director’s stock sale under a Rule 10b5-1 plan?

Yes. The sale was made pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025. Such plans pre-schedule trades, reducing the significance of trade timing as an indicator of the insider’s short-term outlook on the stock.

What does transaction code “S” mean in the Standex (SXI) Form 4 filing?

Transaction code “S” indicates a sale of common stock in the open market or a private transaction. In this case, it reflects the director’s 50-share sale at $272.82 per share, recorded as a routine disposition rather than a grant, gift, or option exercise.